Cargando…
ALG12‐CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant
BACKGROUND: Congenital disorder of glycosylation (CDG) type I is a group of rare disorders caused by recessive mutations in up to 25 genes that impair the N‐glycan precursor formation and its transfer to proteins resulting in hypoglycosylation of multiple proteins. Congenital disorder of glycosylati...
Autores principales: | de la Morena‐Barrio, María Eugenia, Sabater, María, de la Morena‐Barrio, Belén, Ruhaak, Renee L., Miñano, Antonia, Padilla, José, Toderici, Mara, Roldán, Vanessa, Gimeno, Juan R., Vicente, Vicente, Corral, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434597/ https://www.ncbi.nlm.nih.gov/pubmed/32530140 http://dx.doi.org/10.1002/mgg3.1304 |
Ejemplares similares
-
Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway
por: López-Gálvez, Raquel, et al.
Publicado: (2020) -
Incidence and features of thrombosis in children with inherited antithrombin deficiency
por: de la Morena-Barrio, Belén, et al.
Publicado: (2019) -
Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency
por: Toderici, Mara, et al.
Publicado: (2016) -
Correction: Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency
por: Toderici, Mara, et al.
Publicado: (2016) -
GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients
por: de la Morena-Barrio, Maria E, et al.
Publicado: (2013)